Alpha-thalassemia

164,211views

Alpha-thalassemia

Watch later

Watch later

Type III hypersensitivity
Type I hypersensitivity
Type II hypersensitivity
Type IV hypersensitivity
Viral hepatitis
Diabetes mellitus: Pathology review
Hypothyroidism: Pathology review
Ischemic stroke
Lung volumes and capacities
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Multiple sclerosis
Emphysema
Chronic bronchitis
Alzheimer disease
Parkinson disease
Subarachnoid hemorrhage
Stroke: Clinical
Bacterial epiglottitis
Restrictive lung diseases
Cushing syndrome
Diabetes insipidus
Diabetic nephropathy
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Acid reducing medications
Laxatives and cathartics
Muscarinic antagonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Anti-parkinson medications
PDE5 inhibitors
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Azoles
Miscellaneous antifungal medications
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Iron deficiency anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Lymphoma: Clinical
Mycobacterium tuberculosis (Tuberculosis)
Systemic lupus erythematosus (SLE): Clinical
Rheumatoid arthritis: Clinical
Pneumonia: Clinical
Sleep apnea
Lithium
Anxiety disorders: Clinical
Leukemia: Clinical
Microcytic anemia: Pathology review
Anemia: Clinical
Alpha-thalassemia
Beta-thalassemia
Asthma: Clinical
Asthma
Asthma: Information for patients and families (The Primary School)
Heart failure: Clinical
Hypertension: Clinical
Menopause
Coronary artery disease: Clinical
Deep vein thrombosis
Abnormal heart sounds
Valvular heart disease: Clinical
Heart failure: Pathology review

Transcript

Watch video only

Alpha-thalassemia is a genetic disorder where there’s a deficiency in production of the alpha globin chains of hemoglobin, which is the oxygen-carrying protein in red blood cells.

Normally, hemoglobin is made up of four globin chains, each bound to a heme group. There are four major types of globin chains- alpha (α), beta (β), gamma (γ), and delta (δ). These four globin chains combine in different ways to give rise different kinds of hemoglobin. First, there’s hemoglobin F (or HbF), where F stands for fetal hemoglobin, and it’s made up of two α-globin and two γ-globin chains. Hemoglobin A (or HbA) is the major form of adult hemoglobin, made up of two α-globin and two β-globin chains. Finally, hemoglobin A2 (or HbA2) amounts for a small fraction of adult hemoglobin in the blood, and it’s made up of two α-globin and two δ-globin chains. Alpha chain synthesis is controlled by four alpha genes, two on each copy of chromosome 16. And alpha thalassemia is caused by mutations in the alpha genes, most commonly a gene deletion. The mutations are inherited in an autosomal recessive pattern, which means that you need mutated genes from both parents to get the disease. If a person has one defective alpha gene, they’re called a silent carrier, because they don’t have symptoms, but can still pass the gene to their children. If a person has two defective alpha genes, the person has alpha thalassemia minor, which causes mild symptoms. This can either be caused by a ‘cis’ deletion, where mutated genes are on the same chromosome; or a ‘trans’ deletion when the mutated genes are on two different chromosomes. Cis-deletion variants are more prevalent in Asian populations, whereas, trans-deletion variants are more prevalent in African populations.

If there are three defective alpha genes, there’s moderate disease, called hemoglobin H, or HbH, disease. This is caused by excess beta chains, which clump together within developing red blood cells to form tetramers (β4), and give rise to a form of hemoglobin called hemoglobin H. HbH molecules cause hypoxia in two ways. First, they damage the red blood cell membrane, resulting in intramedullary hemolysis, or red blood cell breakdown in the bone marrow; or extravascular hemolysis, when red blood cells are destroyed by macrophages in the spleen. Second, HbH has very high affinity for oxygen, and doesn’t release oxygen to the tissues. And a consequence of hypoxia is that it signals the bone marrow, as well as extramedullary tissues like the liver and spleen, to increase production of red blood cells. This may cause the bones that contain bone marrow, as well as the liver and spleen, to enlarge.

Finally, if all four alpha genes are deleted, it results in Hb Bart’s hydrops fetalis. The problem here begins during fetal life, where gamma chains form tetramers in the absence of alpha chains, called Hb Bart’s (γ4). And It has super duper high affinity for oxygen, about 100 times that of normal Hb! So, the tissues get no oxygen, resulting in severe hypoxia. Severe hypoxia leads to high-output cardiac failure and massive hepatosplenomegaly, resulting in edema all over the body, called hydrops fetalis. This condition is incompatible with life, and without treatment, the fetus usually dies in utero, or soon after birth!

Key Takeaways

Alpha-thalassemia is an inherited blood disorder in which there is insufficient production of alpha globin chains of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen from the lungs to all parts of the body. Symptoms will vary depending on the extent of the deficiency of the globin chains. Some people with alpha-thalassemia do not have symptoms, while others experience mild to moderate anemia.

Sources

  1. "Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-Book" Elsevier Health Sciences (2014)
  2. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  3. "Alpha and beta thalassemia" PubMed (2009)
  4. "Alpha Thalassemia" NCBI (2021)
  5. "The α-Thalassemias" New England Journal of Medicine (2014)
  6. "Alpha thalassemia" MedlinePlus (2017)